
News
-
Minaris Regenerative Medicine and TFBS Announce Strategic Partnership to Advance Cell and Gene Therapy
2024-10-02 Minaris Regenerative Medicine and TFBS Announce Strategic Partnership to Advance Cell and Gene Therapy Minaris Regenerative Medicine, LLC (Minaris) and TFBS Bioscience Inc. (TFBS) are pleased to announce a strategic partnership in cell and gene therapy (CGT) mainly in North America. This collaboration is designed to enhance their capabilities to drive industry innovation by providing the one-stop-shop solutions. Learn more
-
President of TFBS Bioscience Inc. from Taiwan and Officials from National Taiwan University Visit President NAGATA
2024-05-08 President of TFBS Bioscience Inc. from Taiwan and Officials from National Taiwan University Visit President NAGATA President of TFBS Bioscience Inc. from Taiwan and Officials from National Taiwan University Visit President NAGATA Learn more
-
Mie University and BioComo Inc. Team up to Develop Nasal Spray Vaccine against Respiratory Syncytial Virus in Japan with the Manufacturing Contractor, TFBS Bioscience Inc.
2024-04-25 Mie University and BioComo Inc. Team up to Develop Nasal Spray Vaccine against Respiratory Syncytial Virus in Japan with the Manufacturing Contractor, TFBS Bioscience Inc. Mie University and BioComo Inc. Team up to Develop Nasal Spray Vaccine against Respiratory Syncytial Virus in Japan with the Manufacturing Contractor, TFBS Bioscience Inc. Learn more
-
TFBS Brochure
2023-04-07 TFBS Brochure Learn more